Titlebook: endoCANNABINOIDS; Actions at Non-CB1/C Mary E. Abood,Roger G Sorensen,Nephi Stella Book 2013 Springer Science+Business Media New York 2013

阿諛?lè)畛?/a>

書(shū)目名稱(chēng)endoCANNABINOIDS影響因子(影響力)




書(shū)目名稱(chēng)endoCANNABINOIDS影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)endoCANNABINOIDS網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)endoCANNABINOIDS網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)endoCANNABINOIDS被引頻次




書(shū)目名稱(chēng)endoCANNABINOIDS被引頻次學(xué)科排名




書(shū)目名稱(chēng)endoCANNABINOIDS年度引用




書(shū)目名稱(chēng)endoCANNABINOIDS年度引用學(xué)科排名




書(shū)目名稱(chēng)endoCANNABINOIDS讀者反饋




書(shū)目名稱(chēng)endoCANNABINOIDS讀者反饋學(xué)科排名

公式

FRAX-tool

誓言

nutrition

GPR18 and NAGly Signaling: New Members of the Endocannabinoid Family or Distant Cousins?C) and .arachidonoyl glycine (NAGly) by an oxygenated metabolite of the endogenous cannabinoid anandamide (AEA). The review will outline what is known about this receptor, the ligands that activate and block the receptor, and how these interactions fit within cannabinoid/endocannabinoid signaling.

吃掉

978-1-4899-8846-1Springer Science+Business Media New York 2013

吃掉

異端

Nanostructure Science and Technologyptors, G protein-coupled receptors (GPCRs) identified by molecular cloning in the early 1990s. Since that time, there has been a growing body of pharmacological evidence indicating the existence of additional molecular targets for cannabinoids. This chapter overviews the nonclassical targets thought

小淡水魚(yú)

https://doi.org/10.1007/978-94-011-2538-3ein-coupled receptors (GPCRs) that bind constituents of ., such as the classical cannabinoid agonist (?)-.-delta-9-tetrahydrocannabinol [(?)-Δ.-THC (.)]. CB.R and CB.R bind four other structural classes of ligands (see Fig. 2.1): nonclassical cannabinoid agonists typified by 2-[5-Hydroxy-2-(3-hydrox

LAVE